Trifluridine receives positive opinion from CHMP in the EU for patients with previously treated metastatic gastric cancer

10:23 EDT 26 Jul 2019 | ecancermedicalscience

It has been announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for trifluridine as monotherapy for the treatment of adult patients with metastatic gastric...

More From BioPortfolio on "Trifluridine receives positive opinion from CHMP in the EU for patients with previously treated metastatic gastric cancer"